DIATHEVA launches for the first time PBRT 2.0
The PBRT (PCR Based Replicon Typing) is an essential [...]
Diatheva coordinates: PrInT-Age “Un approccio integrato per la promozione della salute degli anziani e delle persone fragili: prevenzione delle infezioni, integrazione nutrizionale e terapie personalizzate”
Print-Age is a POR MARCHE FESR 2014-2020 funded project [...]
BIO 2016 : DIATHEVA presents “scFv 2G8” monoclonal antibody a new approach to fungal infections
DIATHEVA presented a new product in pipeline "scFv 2G8" [...]
New pubblication Diatheva’s pipeline antibody therapeutics
Diatheva’s pipeline antibody-based therapies is designated to address significant unmet [...]
Agenus Acquires from Diatheva Novel Antibodies to Immuno-oncology Target CEACAM1
Target Expressed on Lymphocytes and Tumors Offers Unique Advantages for [...]
The new Italian guideline for the prevention and control of Legionellosis were approved
New Italian guidelines for the prevention and control of legionellosis [...]
Detection and quantification of Legionella spp
It’s spring , the right time for monitoring Legionella spp. [...]
DIATHEVA , partner in the co-development of a recombinant antibody for the treatment of Ewing Sarcoma
A recent paper published in the prestigious scientific journal Clinical [...]